Table 3.
Clinical endpoints following transcatheter aortic valve implantation procedure
|
|
Whole group (n = 348)
|
No coronary angiogram group (n = 194)
|
Coronary angiogram group (n = 154)
|
P
value
|
| Primary endpoint, n (%) | 78 (22.4) | 44 (22.6) | 33 (22.2) | NS |
| Death, n (%) | 63 (18.1) | 37 (19.0) | 26 (17.0) | NS |
| Myocardial infarction, n (%) | 8 (2.3) | 2 (1.0) | 6 (3.9) | NS |
| Readmission with heart failure, n (%) | 14 (4) | 12 (6.2) | 2 (1.3) | < 0.05 |
| Coronary angiogram post valve intervention, n (%) | 10 (2.9) | 1 (0.5) | 9 (5.8) | < 0.01 |
| Death & myocardial infarction, n (%) | 69 (19.8) | 38 (19.5) | 31 (20.3) | NS |
| Death & readmission with heart failure, n (%) | 70 (20.1) | 43 (22.1) | 27 (17.6) | NS |
| Myocardial infarction & readmission with heart failure, n (%) | 21 (6) | 13 (6.7) | 8 (5.2) | NS |
Primary endpoint was defined as a composite of death, myocardial infarction, revascularisation, and readmission with heart failure. NS: No significant difference.